Serina Therapeutics (SER) Net Margin Growth (3y) (2021 - 2025)
Serina Therapeutics (SER) Net Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | -5,319.00 |
| 10 | Serina Therapeutics | 44.84 Mn | 21.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.72 Mn |
| Sep 30, 2024 | -3.87 Mn |
| Jun 30, 2024 | -880,715.00 |
| Mar 31, 2024 | -5.99 Mn |
| Dec 31, 2023 | 20,017.00 |
| Sep 30, 2023 | -533,023.00 |
| Jun 30, 2023 | -1.44 Mn |
| Mar 31, 2023 | -332,030.00 |
| Dec 31, 2022 | -2.18 Mn |
| Sep 30, 2022 | -2.63 Mn |
| Jun 30, 2022 | -2.10 Mn |
| Mar 31, 2022 | -5.33 Mn |
| Sep 30, 2021 | 54,583.00 |
| Jun 30, 2021 | 43,939.00 |